Migvax
MigVax is a startup developing Migvax-101, a novel oral subunit COVID-19 vaccine that has demonstrated effectivity in pre-clinical tests as a booster for previously vaccinated persons
7-day free trial · no credit card
Verified contacts
7
available on Kipplo
LinkedIn employees
9
11 to 50 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 7 verified contacts at Migvax
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
7 contacts with verified email or phone · masked until revealed.
- RB
Ran Ben Adiva
Head of Bioprocess · Manufacturing & Production
EmailPhone - OC
Ofira C.
VP R & d · Science
EmailPhone - DZ
David Zigdon
President · Other
EmailPhone - GR
Galina Rodionov
Director of Quality · Other
EmailPhone
Showing 4 of 7 verified contacts
Top roles at Migvax
5 distinct titles indexed · top 5 shown.
- 2research assistant
- 2vp r & d
- 1director of quality
- 1head of bioprocess
- 1president
Sign up to unlock all 7 contacts at Migvax
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 7 verified contacts at Migvax
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.